Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster biopsy - sentinel

Terms

28biopsy
49sentinel
79node
95lymph
64axillary
20clearance
12dema
4dye

Associations

Freq.WeightAssociation
270.729biopsy - sentinel
430.691node - sentinel
520.600lymph - node
270.574biopsy - node
300.440lymph - sentinel
170.475axillary - clearance
290.408axillary - node
120.355dema - lymph
180.349biopsy - lymph
40.286dye - sentinel
200.256axillary - lymph
100.252clearance - node
40.225dye - node
120.214axillary - sentinel
40.205dye - lymph
60.138clearance - lymph
Documents par ordre de pertinence
000066 (2017) R M Parks [Royaume-Uni] ; K L Cheung [Royaume-Uni]Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.
000089 (2016) Mina M G. Youssef [Royaume-Uni] ; Diane Cameron [Royaume-Uni] ; Philip H. Pucher [Royaume-Uni] ; Sisse Olsen [Royaume-Uni] ; Douglas Ferguson [Royaume-Uni]The significance of sentinel lymph node micrometastasis in breast cancer: Comparing outcomes with and without axillary clearance.
000120 (2016) Mirjam Cl Peek [Royaume-Uni] ; Tibor Kovacs [Royaume-Uni] ; Rose Baker [Royaume-Uni] ; Hisham Hamed [Royaume-Uni] ; Ash Kothari [Royaume-Uni] ; Michael Douek [Royaume-Uni]Is blue dye still required during sentinel lymph node biopsy for breast cancer?
000397 (2013) Metehan Gumus [Turquie] ; Hatice Gumus [Turquie] ; Sue E. Jones [Royaume-Uni] ; Peter A. Jones [Royaume-Uni] ; Ali R. Sever [Royaume-Uni] ; Jennifer Weeks [Royaume-Uni]How Long Will I Be Blue? Prolonged Skin Staining Following Sentinel Lymph Node Biopsy Using Intradermal Patent Blue Dye
000594 (2011) Anastasia Pazaiti [Royaume-Uni] ; Ian S. Fentiman [Royaume-Uni]Which Patients Need an Axillary Clearance after Sentinel Node Biopsy?
000775 (2010) Y. Moghaddam [Royaume-Uni] ; M. Falzon [Royaume-Uni] ; L. Fulford [Royaume-Uni] ; N. R. Williams [Royaume-Uni] ; M. R. Keshtgar [Royaume-Uni]Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer
000959 (2007) Robert M. Kirby [Royaume-Uni] ; Abdul Basit [Royaume-Uni] ; Quang T. Nguyen [Royaume-Uni] ; Anthony Jaipersad [Royaume-Uni] ; Rebecca Billingham [Royaume-Uni]Three stage axillary lymphatic massage optimizes sentinel lymph node localisation using blue dye
000E54 (2001) Chi-Kin Chung [Royaume-Uni] ; Wai-Ka Hung ; Miranda Chi-Mui Chan ; Yvonne Lau ; Kong-Ling Mak ; Andrew Wai-Chun YipEarly experience of sentinel lymph node biopsy in breast cancer with blue dye technique
000058 (2017) J A Moody [Royaume-Uni] ; R F Ali [Royaume-Uni] ; A C Carbone [Royaume-Uni] ; S. Singh [Royaume-Uni] ; J T Hardwicke [Royaume-Uni]Complications of sentinel lymph node biopsy for melanoma - A systematic review of the literature.
000096 (2016) Gianpiero Manca [Royaume-Uni] ; Elisa Tardelli ; Domenico Rubello ; Marta Gennaro ; Maria Cristona Marzola ; Gary J. Cook ; Duccio VolterraniSentinel lymph node biopsy in breast cancer: a technical and clinical appraisal.
000211 (2015) Nigel J. Bundred [Royaume-Uni] ; Nicola L P. Barnes [Royaume-Uni] ; Emiel Rutgers [Pays-Bas] ; Mila Donker [Pays-Bas]Is axillary lymph node clearance required in node-positive breast cancer?
000279 (2014) C. Meads [Royaume-Uni] ; A J Sutton [Royaume-Uni] ; A N Rosenthal [Royaume-Uni] ; S. Małysiak [Pologne] ; M. Kowalska [Pologne] ; A. Zapalska [Pologne] ; E. Rogozi Ska [Royaume-Uni] ; P. Baldwin [Royaume-Uni] ; R. Ganesan [Royaume-Uni] ; E. Borowiack [Royaume-Uni] ; P. Barton [Royaume-Uni] ; T. Roberts [Royaume-Uni] ; K. Khan [Royaume-Uni] ; S. Sundar [Royaume-Uni]Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis
000390 (2013) Darren K. Patten [Royaume-Uni] ; Daniel R. Leff ; Zubair Wani ; Susan J. Cleator ; Carlo Palmieri ; R Charles Coombes ; Dimitri J. HadjiminasIs the presence of small volume disease in the sentinel node an indication for axillary clearance?
000405 (2013) A J Sutton [Royaume-Uni] ; P. Barton [Royaume-Uni] ; S. Sundar [Royaume-Uni] ; C. Meads [Royaume-Uni] ; A N Rosenthal [Royaume-Uni] ; P. Baldwin [Royaume-Uni] ; K. Khan [Royaume-Uni] ; T E Roberts [Royaume-Uni]Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer
000443 (2013) Amy Burger [Royaume-Uni] ; David Thurtle [Royaume-Uni] ; Sally Owen [Royaume-Uni] ; Gurdeep Mannu [Royaume-Uni] ; Simon Pilgrim [Royaume-Uni] ; Raman Vinayagam [Royaume-Uni] ; Simon Pain [Royaume-Uni]Sentinel Lymph Node Biopsy for Risk‐Reducing Mastectomy
000473 (2013) P. De Mozzi ; P. Da Forno ; N. Yii [Royaume-Uni] ; K. HarmanAn unusual complication of axillary lymph‐node clearance
000563 (2012) Ansar Farooq [Niger] ; Mysore Chandrshekar [Royaume-Uni] ; Kieran HorganRole of sentinel lymph node biopsy in patients with ductal carcinoma in situ and microinvasion
000668 (2011) J. R. Benson [Royaume-Uni] ; G. C. Wishart [Royaume-Uni]Role of axillary clearance for patients with sentinel node‐positive early breast cancer
000731 (2010) Dean Fulford [Royaume-Uni] ; Sam Dalal [Royaume-Uni] ; John Winstanley [Royaume-Uni] ; Mike J. Hayton [Royaume-Uni]Hand surgery after axillary lymph node clearance for breast cancer: contra-indication to surgery?
000902 (2008) Amit Goyal [Royaume-Uni] ; Robert G. Newcombe ; Alok Chhabra ; Robert E. ManselMorbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
000980 (2007) George M. Filippakis [Royaume-Uni] ; George Zografos [Grèce]Contraindications of sentinel lymph node biopsy: Áre there any really?
000A51 (2006) L. Calabrese [Italie] ; R. Bruschini [Italie] ; M. Ansarin [Italie] ; G. Giugliano [Italie] ; C. De Cicco [Italie] ; F. Ionna [Italie] ; G. Paganelli [Italie] ; F. Maffini [Italie] ; Ja Werner [Allemagne] ; D. Soutar [Royaume-Uni]Role of sentinel lymph node biopsy in oral cancer
000B25 (2005) Simon J. Pain [Royaume-Uni] ; Robert W. Barber ; Chandra K. Solanki ; James R. Ballinger ; Tom Bennett Britton ; Peter S. Mortimer ; Anand D. Purushotham ; A Michael PetersShort-term effects of axillary lymph node clearance surgery on lymphatic physiology of the arm in breast cancer.
000B27 (2005) A. Adwani [Royaume-Uni] ; Sr Ebbs [Royaume-Uni] ; S. Burton [Royaume-Uni] ; S. Lowe [Royaume-Uni]Sentinel node biopsy should be supplemented by axillary sampling in patients with small breast cancers
000B34 (2005) Anand David Purushotham [Royaume-Uni] ; Sara Upponi ; Manfred Borislav Klevesath ; Lynda Bobrow ; Keith Millar ; Jonathan Peter Myles ; Stephen William DuffyMorbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
000B91 (2004) Amit Goyal [Royaume-Uni] ; Robert E. Mansel [Royaume-Uni]Current status of sentinel lymph node biopsy in solid malignancies
000C02 (2004) Tiziana Catzeddu [Italie] ; Gianfilippo Bertelli [Royaume-Uni] ; Lucia Del Mastro [Italie] ; Marco Venturini [Italie]Sentinel lymph node biopsy in breast cancer patients: The medical oncology perspective
000E80 (2000) Sd Pendry [Royaume-Uni]A radiographer's perspective of sentinel lymph node biopsy
000F05 (2000) S. P. Hettiaratchy [Royaume-Uni] ; N. Kang [Royaume-Uni] ; G. A. O'Toole [Royaume-Uni] ; B. W. E. M. Powell [Royaume-Uni] ; R. Allan [Royaume-Uni] ; M. G. Cook [Royaume-Uni]Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients
001009 (1999) M. R. S. Keshtgar [Royaume-Uni] ; C. Saunders [Royaume-Uni] ; P. J. Ell [Royaume-Uni] ; M. Baum [Royaume-Uni]Langer's axillary arch in association with sentinel lymph node
000156 (2016) Mia Schmidt-Hansen [Royaume-Uni] ; Nathan Bromham [Royaume-Uni] ; Elise Hasler [Royaume-Uni] ; Malcolm W. Reed [Royaume-Uni]Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses
000170 (2015) Nazera Dodia [Royaume-Uni] ; Deena El-Sharief ; Cliona C. Kirwan [Royaume-Uni]The use of isotope injections in sentinel node biopsy for breast cancer: are the 1- and 2-day protocols equally effective?
000239 (2015) Nigel J. Bundred [Royaume-Uni] ; Charlotte Stockton ; Vaughan Keeley ; Katie Riches ; Linda Ashcroft ; Abigail Evans ; Anthony Skene ; Arnie Purushotham ; Maria Bramley ; Tracey HodgkissComparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer.
000260 (2015) S K Bains [Royaume-Uni] ; A W B. Stanton [Royaume-Uni] ; V. Cintolesi [Royaume-Uni] ; J. Ballinger [Royaume-Uni] ; S. Allen [Royaume-Uni] ; C. Zammit [Royaume-Uni] ; J R Levick [Royaume-Uni] ; Peter Mortimer (dermatologue)‎ [Royaume-Uni] ; A M Peters [Royaume-Uni] ; A D Purushotham [Royaume-Uni]A constitutional predisposition to breast cancer-related lymphoedema and effect of axillary lymph node surgery on forearm muscle lymph flow.
000416 (2013) Amit Goyal [Royaume-Uni] ; Lelia Duley [Royaume-Uni] ; Apostolos Fakis [Royaume-Uni]Axillary treatment for patients with early breast cancer and lymph node metastasis: systematic review protocol
000437 (2013) J. M. Mcgregor [Royaume-Uni]Too much surgery and too little benefit? Sentinel node biopsy for melanoma as it currently stands
000468 (2013) Laura Johnson [Royaume-Uni] ; Sarah E. Pinder [Royaume-Uni] ; Michael Douek [Royaume-Uni]Deposition of superparamagnetic iron‐oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection
000565 (2012) A. P. T. Van Der Ploeg [Pays-Bas] ; A. C. J. Van Akkooi [Pays-Bas] ; P. Rutkowski [Pologne] ; M. Cook [Royaume-Uni] ; O. E. Nieweg [Pays-Bas] ; C. R. Rossi [Italie] ; A. Testori [Italie] ; S. Suciu [Belgique] ; C. Verhoef [Pays-Bas] ; A. M. M. Eggermont [France]Prognosis in patients with sentinel node‐positive melanoma without immediate completion lymph node dissection
000613 (2011) K L Cooper [Royaume-Uni] ; S. Harnan ; Y. Meng ; S E Ward ; P. Fitzgerald ; D. Papaioannou ; L. Wyld ; C. Ingram ; I D Wilkinson ; E. LorenzPositron emission tomography (PET) for assessment of axillary lymph node status in early breast cancer: A systematic review and meta-analysis.
000639 (2011) Y. Meng [Royaume-Uni] ; S. Ward ; K. Cooper ; S. Harnan ; L. WyldCost-effectiveness of MRI and PET imaging for the evaluation of axillary lymph node metastases in early stage breast cancer.
000767 (2010) S. Nicholson [Royaume-Uni]New anatomical classification of the axilla with implications for sentinel node biopsy (Br J Surg 2010; 97: 1659–1665)
000799 (2009) Alireza Hamidian Jahromi [Royaume-Uni] ; Sankaran Narayanan [Royaume-Uni] ; Fiona Macneill [Royaume-Uni] ; Peter Osin [Royaume-Uni] ; Ashutash Nerurkar [Royaume-Uni] ; Gerald Gui [Royaume-Uni]Testing the Feasibility of Intra-Operative Sentinel Lymph Node Touch Imprint Cytology
000907 (2008) Benjamin Bird [États-Unis] ; Milos Miljkovic [États-Unis] ; Melissa J. Romeo [États-Unis] ; Jennifer Smith [Royaume-Uni] ; Nicholas Stone [Royaume-Uni] ; Michael W. George [Royaume-Uni] ; Max Diem [États-Unis]Infrared micro-spectral imaging: distinction of tissue types in axillary lymph node histology
000A25 (2007) Robert G. Newcombe [Royaume-Uni]Bayesian estimation of false‐negative rate in a clinical trial of sentinel node biopsy
000C19 (2004) J E A. Somner [Royaume-Uni] ; J M J. Dixon [Royaume-Uni] ; J S J. Thomas [Royaume-Uni]Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status
000E24 (2001) D. Clarke [Royaume-Uni] ; R. Mansel [Royaume-Uni]Sentinel node biopsy in breast cancer
000E30 (2001) S. P. Harden [Royaume-Uni] ; A. J. Neal [Royaume-Uni] ; N. Al-Nasiri [Royaume-Uni] ; S. Ashley [Royaume-Uni] ; G. Querci Della Rovere [Royaume-Uni]Predicting axillary lymph node metastases in patients with T1infiltrating ductal carcinoma of the breast
000F57 (1999) C. Yiangou ; S. Shousha [Royaume-Uni] ; H D SinnettPrimary tumour characteristics and axillary lymph node status in breast cancer
000F90 (1999) G. Howard-Alpe [Royaume-Uni]Sentinel Node Localization and Biopsy in Breast Cancer
001086 (1998) David N. Krag [Royaume-Uni]Minimal access surgery for staging regional lymph nodes: The sentinel-node concept
001088 (1998) S. A. Mcintosh [Royaume-Uni] ; S. A. Purushotham [Royaume-Uni]Lymphatic mapping and sentinel node biopsy in breast cancer
001256 (1995) Tim Davidson [Royaume-Uni]Why I favour axillary node clearance in the management of breast cancer
001520 (1990) H. Marcus [Royaume-Uni] ; J. Pawade [Royaume-Uni] ; E. J. Vella [Royaume-Uni]Painful lymphatic occlusion following axillary lymph node surgery
001794 (1967) A. J. J. Emmett [Royaume-Uni] ; J. N. Barron [Royaume-Uni] ; N. Veall [Royaume-Uni]The use of I131 albumin tissue clearance measurements and other physiological tests for the clinical assessment of patients with lymphœdema
000005 (2017) Christos Iavazzo [Royaume-Uni] ; Paraskevi-Evangelia Iavazzo [Grèce] ; Ioannis D. Gkegkes [Grèce]The possible role of the da Vinci robot for patients with vulval carcinoma undergoing inguinal lymph node dissection
000055 (2017) Damian Mullan [Royaume-Uni] ; Damir Kosutic [Royaume-Uni]Contrast CT-scan for preoperative planning of VSLN (vascularized submental lymph-node) transfer.
000258 (2015) Alexandros Laios [Royaume-Uni] ; Davide Volpi [Royaume-Uni] ; Iain D. C. Tullis [Royaume-Uni] ; Martha Woodward [Royaume-Uni] ; Stephen Kennedy [Royaume-Uni] ; Pubudu N. J. Pathiraja [Royaume-Uni] ; Krishnayan Haldar [Royaume-Uni] ; Borivoj Vojnovic [Royaume-Uni] ; Ahmed A. Ahmed [Royaume-Uni]A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging system
000280 (2014) Adam S. Baumgarten [États-Unis] ; Eihab Alhammali [États-Unis] ; Tariq S. Hakky [États-Unis] ; Patrick N. Espiritu [États-Unis] ; Julio M. Pow-Sang [États-Unis] ; Wade J. Sexton [États-Unis] ; Jorge L. Lockhart [États-Unis] ; Chris Protzel [Allemagne] ; Oliver Hakenberg [Allemagne] ; Asif Muneer [Royaume-Uni] ; Philippe E. Spiess [États-Unis]Salvage surgical resection for isolated locally recurrent inguinal lymph node metastasis of penile cancer: international study collaboration.
000612 (2011) Elly Brockbank [Royaume-Uni] ; Fani Kokka [Royaume-Uni] ; Andrew Bryant [Royaume-Uni] ; Christophe Pomel [France] ; Karina Reynolds [Royaume-Uni]Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer
000614 (2011) Katherine M. Burnand [Royaume-Uni] ; Daphne M. Glass ; Sumati Sundaraiya ; Peter S. Mortimer ; A Michael PetersPopliteal node visualization during standard pedal lymphoscintigraphy for a swollen limb indicates impaired lymph drainage.
000670 (2011) M. C. Swan [Royaume-Uni] ; D. W. Oliver [Royaume-Uni] ; O. C. S. Cassell [Royaume-Uni] ; D. J. Coleman [Royaume-Uni] ; N. Williams [Royaume-Uni] ; D. G. Morritt [Royaume-Uni] ; H. P. Giele [Royaume-Uni]Randomized controlled trial of fibrin sealant to reduce postoperative drainage following elective lymph node dissection
000681 (2011) D. M. Layfield [Royaume-Uni] ; A. Agrawal [Royaume-Uni] ; H. Roche [Royaume-Uni] ; R. I. Cutress [Royaume-Uni]Intraoperative assessment of sentinel lymph nodes in breast cancer
000698 (2011) Katherine M. Burnand [Royaume-Uni] ; Daphne M. Glass [Royaume-Uni] ; Sumati Sundaraiya [Royaume-Uni] ; Peter S. Mortimer [Royaume-Uni] ; A. Michael Peters [Royaume-Uni]Popliteal Node Visualization During Standard Pedal Lymphoscintigraphy for a Swollen Limb Indicates Impaired Lymph Drainage
000760 (2010) Stephen M. Kihara [Royaume-Uni] ; Neil A. Giblett [Royaume-Uni] ; Catriona Mcneil ; Paul Crea [Australie]Sentinel node micrometastases in breast cancer: Clinical outcome
000766 (2010) M. R. S. Keshtgar [Royaume-Uni] ; D. W. Chicken [Royaume-Uni] ; M. R. Austwick [Royaume-Uni] ; S. K. Somasundaram [Royaume-Uni] ; C. A. Mosse [Royaume-Uni] ; Y. Zhu [Royaume-Uni] ; I. J. Bigio [États-Unis] ; S. G. Bown [Royaume-Uni]Optical scanning for rapid intraoperative diagnosis of sentinel node metastases in breast cancer
000818 (2009) Rajmohan Murali [Australie] ; Alistair J. Cochran [États-Unis] ; Martin G. Cook [Royaume-Uni] ; Joseph D. Hillman [États-Unis] ; Rooshdiya Z. Karim [Australie] ; Marc Moncrieff [Australie] ; Hans Starz [Allemagne] ; John F. Thompson [Australie] ; Richard A. Scolyer [Australie]Inter-observer reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma
000898 (2008) J S Tanguay [Royaume-Uni] ; D R Ford ; G. Sadler ; L. Buckley ; H. Uppal ; J. Cross ; N. Holmes ; K. Fortes Mayer ; I. FernandoSelective axillary node sampling and radiotherapy to the axilla in the management of breast cancer.
000941 (2008) Christopher P. Allan [Royaume-Uni, Australie] ; Andrew J. Hayes [Royaume-Uni] ; J. Meirion Thomas [Royaume-Uni]ILIOINGUINAL LYMPH NODE DISSECTION FOR PALPABLE METASTATIC MELANOMA TO THE GROIN
000A38 (2007) Anand D. Purushotham [Royaume-Uni] ; Thomas M. Bennett Britton [Royaume-Uni] ; Manfred B. Klevesath [Royaume-Uni] ; Patrick Chou [Royaume-Uni] ; Olorunsola F. Agbaje [Royaume-Uni] ; Stephen W. Duffy [Royaume-Uni]Lymph node status and breast cancer-related lymphedema
000A43 (2006) J. Balega [Royaume-Uni] ; P O Van Trappen [Royaume-Uni]The sentinel node in gynaecological malignancies
000A65 (2006) J. Mathew [Royaume-Uni] ; L. Barthelmes ; S. Neminathan ; D. CrawfordComparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery.
000B48 (2005) D. Sahni [Royaume-Uni] ; A. Robson ; G. Orchard ; R. Szydlo [Royaume-Uni] ; A V Evans [Royaume-Uni] ; R. Russell-Jones [Royaume-Uni]The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status
000B51 (2005) R. Russell-Jones [Royaume-Uni]Sentinel node and survival in melanoma
000C33 (2004) G. Cserni [Hongrie] ; I. Amendoeira [Portugal] ; N. Apostolikas [Grèce] ; J P Bellocq [France] ; S. Bianchi [Italie] ; W. Boecker [Allemagne] ; B. Borisch [Suisse] ; C E Connolly [Irlande (pays)] ; T. Decker [Allemagne] ; P. Dervan [Irlande (pays)] ; M. Drijkoningen [Belgique] ; I O Ellis [Royaume-Uni] ; C W Elston [Royaume-Uni] ; V. Eusebi [Italie] ; D. Faverly [Belgique] ; P. Heikkila [Finlande] ; R. Holland [Pays-Bas] ; H. Kerner [Israël] ; J. Kulka [Hongrie] ; J. Jacquemier [France] ; M. Lacerda [Portugal] ; J. Martinez-Penuela [Espagne] ; C. De Miguel [Espagne] ; J L Peterse [Pays-Bas] ; F. Rank [Danemark] ; P. Regitnig [Autriche] ; A. Reiner [Autriche] ; A. Sapino [Italie] ; B. Sigal-Zafrani [France] ; A M Tanous [Luxembourg (pays)] ; S. Thorstenson [Suède] ; E. Zozaya [Espagne] ; G. Fejes [Hongrie] ; C A Wells [Royaume-Uni]Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology
000E27 (2001) R. J. Kennedy [Royaume-Uni] ; J. Bradley [Royaume-Uni] ; R. W. Parks [Royaume-Uni] ; S. J. Kirk [Royaume-Uni]Prospective evaluation of the morbidity of axillary clearance for breast cancer (Br J Surg 2001; 88: 114–7)
000F11 (2000) T. M. D. Hughes [Royaume-Uni] ; R. P. A'Hern [Royaume-Uni] ; J. M. Thomas [Royaume-Uni]Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma
001018 (1999) T. M. D. Hughes [Royaume-Uni] ; T. M. D. Thomas [Royaume-Uni]Combined inguinal and pelvic lymph node dissection for stage III melanoma
001068 (1998) George W. Flett [Royaume-Uni] ; J. J. Going [Royaume-Uni] ; P. D. Stanton [Royaume-Uni] ; T. G. Cooke [Royaume-Uni]Sentinel node localization in patients with breast cancer
001075 (1998) P. Markandoo [Royaume-Uni] ; P. Smith [Royaume-Uni] ; M. A. Chaudary [Royaume-Uni] ; M. A. Fentiman [Royaume-Uni]Preservation of pectoralis minor in axillary clearance for breast cancer
001255 (1995) Michael J. Greenall [Royaume-Uni]Why I favour axillary node sampling in the management of breast cancer
001274 (1995) K. A. Dookeran [États-Unis] ; S. S. Sikora [États-Unis] ; M. Noguchi [Japon] ; M. Burke [Royaume-Uni]Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance
001327 (1994) D. J. Hadjiminas [Royaume-Uni] ; D. J. Burke [Royaume-Uni]Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance
001368 (1993) C. J. Fisher [Royaume-Uni] ; S. Boyle [Royaume-Uni] ; S. Burke [Royaume-Uni] ; A. B. Price [Royaume-Uni]Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance
001371 (1993) R. N. Scott [Royaume-Uni] ; A. J. Mckay [Royaume-Uni]Elective lymph node dissection in the management of malignant melanoma
001430 (1992) A. L. Hoe [Royaume-Uni] ; D. Iven [Royaume-Uni] ; G. T. Royle [Royaume-Uni] ; G. T. Taylor [Royaume-Uni]Incidence of arm swelling following axillary clearance for breast cancer
001565 (1989) R. J. Aitken [Royaume-Uni] ; M. N. Gaze [Royaume-Uni] ; A. Rodger [Royaume-Uni] ; U. Chetty [Royaume-Uni] ; U. Forrest [Royaume-Uni]Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance
001616 (1987) G. Kissin [Royaume-Uni] ; D. A. Simpson [Royaume-Uni] ; D. Easton [Royaume-Uni] ; H. White ; G. Westbury [Royaume-Uni]Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma
001687 (1984) Frances Browse [Royaume-Uni] ; R. L. Doig [Royaume-Uni] ; D. Sizeland [Royaume-Uni]The resistance of a lymph node to lymph flow
001771 (1971) J. J. Pflug [Royaume-Uni] ; J. S. Calnan [Royaume-Uni]The experimental production of chronic lymphœdema
001795 (1967) James Calnan [Royaume-Uni]Lymphœdema: The case for doubt
001806 (1966) D. O. Maisels [Royaume-Uni]Anonychia in association with lymphœdema
001814 (1965) David J. Crockett [Royaume-Uni]Lymphatic anatomy and lymphœdema
001839 (1959) James Calnan [Royaume-Uni] ; S. C. Truelove [Royaume-Uni]Prednisone in chronic lymphœdema of the legs
001841 (1959) H. F. Hope-Stone [Royaume-Uni] ; E. A. Bence [Royaume-Uni]Lymphangiosarcoma occurring in association with lymphœdema
001847 (1957) J. B. Kinmonth [Royaume-Uni] ; G. W. Taylor [Royaume-Uni] ; G. D. Tracy [Royaume-Uni] ; J. D. Marsh [Royaume-Uni]Primary lymphœdema. Clinical and lymphangiographic studies of a series of 107 patients in which the lower limbs were affected
001852 (1956) John Watson [Royaume-Uni]Lymphœdema pr˦cox and some experiences in its treatment
001862 (1955) Thomas Gibson [Royaume-Uni] ; J. Scott Tough [Royaume-Uni]The surgical correction of chronic lymphœdema of the legs
001868 (1948) Rainsford Mowlem [Royaume-Uni]The treatment of lymphœdema
001870 (1938) E. D. Telford [Royaume-Uni] ; H. T. SimmonsChronic lymphœdema
000025 (2017) Roberta Bianchi [Royaume-Uni] ; Erica Russo [Royaume-Uni] ; Samia B. Bachmann [Royaume-Uni] ; Steven T. Proulx [Royaume-Uni] ; Marko Sesartic [Royaume-Uni] ; Nora Smaadahl [Royaume-Uni] ; Steve P. Watson [Royaume-Uni] ; Christopher D. Buckley [Royaume-Uni] ; Cornelia Halin [Royaume-Uni] ; Michael Detmar [Royaume-Uni]Postnatal Deletion of Podoplanin in Lymphatic Endothelium Results in Blood Filling of the Lymphatic System and Impairs Dendritic Cell Migration to Lymph Nodes.
Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024